Kalpana Shah

In the United States, there are 302 individuals named Kalpana Shah spread across 41 states, with the largest populations residing in New Jersey, California, Illinois.

Public information about Kalpana Shah

Resumes

Qa Analyst

Location:

102 east Main St, Emmett, ID 83617

Industry:

Banking

Work:

Wells Fargo
Qa Analyst Wells Fargo
Loan Review Analyst at Wachovia Bank Wells Fargo Feb 2009 - Jun 2009
Mortgage Loan Specialist Wells Fargo Jun 2007 - Mar 2008
Business Analyst

Education:

Gujarat University 1975 - 1978
Bachelors, Bachelor of Science, Accounting, Finance

Skills:

Mortgage Lending, Credit Analysis, Banking, Credit, Finance

Kalpana Shah

Location:

Washington, DC

Industry:

Accounting

Work:

National Park Service
Revenue Specialist Doi-Nps
Revenue Specialist

Education:

Gujarat University 1965 - 1968

Development Manager At Merck

Location:

7010 Trotting Course Ln, Rego Park, NY 11374

Industry:

Pharmaceuticals

Work:

Merck Apr 1996 - May 2003
Compliance Analyst Merck Apr 1996 - May 2003
Development Manager at Merck

Education:

Stella Maris College 1968 - 1971
Bachelors, Bachelor of Arts, Social Sciences

Medical Technologist

Location:

30 Petes Park Rd, Helen, GA 30545

Industry:

Hospital & Health Care

Work:

Northeast Georgia Health System
Medical Technologist

Pharmacy Technician

Location:

Philadelphia, PA

Industry:

Health, Wellness And Fitness

Work:

Rite Aid
Pharmacy Technician

Education:

S.v.t College of Home Science 1975 - 1979
Bachelors, Bachelor of Science

Skills:

Clinical Research, Community Pharmacy, Compounding, Customer Service, Healthcare, Microsoft Office, Pharmacists, Pharmacy, Pharmacy Automation, Hipaa

Kalpana Shah

Location:

Hockessin, DE

Industry:

Accounting

Work:

Jpmorgan Chase & Co. Aug 2011 - Sep 2014
Business Analyst and Reporting Specialist and Accounting Associate First Data Corporation Dec 2000 - Apr 2011
Senior Accounting Associate J.p. Morgan Aug 1994 - Aug 2000
Credit Operation Specialist J.p. Morgan Nov 1988 - Aug 1994
Senior Reconcilement Clerk

Education:

Gujarat University
Bachelors, Accounting

Skills:

General Ledger, Analysis, Accounting, Banking, Finance, Powerpoint, Financial Reporting, Account Reconciliation, Data Entry, Financial Statements, Time Management, Journal Entries, Process Improvement, Microsoft Word, Internal Audit, Microsoft Office, Microsoft Excel

Phebotomy And Ekg

Location:

New York, NY

Work:

Phebotomy and Ekg

Packaging Supervisor

Work:

Packaging Supervisor

Background search with BeenVerified

Background Search for Kalpana Shah

Phone Address Email Family Social Criminal Property Bankruptcy Residence

Data provided by Veripages

Phones & Addresses

Name

Addresses

Phones

Kalpana P Shah

22 Emily Dr, South Setauket, NY 11720

Kalpana P Shah

607 Woodland Hills Rd, White Plains, NY 10603

914-831-0860, 914-949-8713

Kalpana R. Shah

Gaithersburg, MD

301-540-4386

Kalpana R Shah

13013 Ethel Rose Way, Boyds, MD 20841

301-540-4386

Kalpana R Shah

13103 Millhaven Pl, Germantown, MD 20874

Kalpana Shah

Detroit, MI

313-881-0773

Kalpana R Shah

18005 Cottage Garden Dr, Germantown, MD 20874

301-540-4386

Kalpana A Shah

28 Ptarmigan Dr, Shrewsbury, MA 01545

508-754-5828

Kalpana Shah

4131 Ferro St, Stafford, TX 77477

281-498-7462

Kalpana Shah

598 Austin Creek Dr, Buford, GA 30518

770-945-8591

Kalpana Shah

501 Cypress Ln, East Brunswick, NJ 08816

Kalpana Shah

5 Ashmont Ct, Silver Spring, MD 20906

240-888-7487

Kalpana Shah

8747 Santa Ridge Cir #87, Elk Grove, CA 95624

Kalpana Shah

361-991-4274

Kalpana Shah

89 Cornwall Rd, Ridgewood, NJ 07452

201-725-0667

Kalpana Shah

86 N Grant Ave, Colonia, NJ 07067

732-381-9744

Business Records

Name / Title

Company / Classification

Phones & Addresses

Kalpana H Shah
Managing

VII NII, LLC

124 Buttonwood Ln, Boynton Beach, FL 33436

Kalpana R Shah
Managing

VEER INVESTMENTS LLC
Investor

3048 Aloma Ave, Winter Park, FL 32792

Kalpana Shah
President

KAHAN CO., INC

9838 Hawthorne Dr, Rancho Cucamonga, CA 91730

Kalpana Shah
Managing

Little Springs Properties, LLC

5250 Little Wood Ln, Dayton, OH 45429

Kalpana S Shah
Director, Secretary

SGM SUPPLY, INC
Whol Industrial Supplies

6015 Commerce Dr STE 450, Irving, TX 75063
8100 Sycamore Dr, Irving, TX 75063
972-714-4704

Kalpana P. Shah
Director

BVM MANAGEMENT CO
Hotel/Motel Operation

1751 Lexington Rd, Richmond, KY 40475
859-623-9121

Kalpana N. Shah
General Partner

THE BERKSHIRE FAMILY LIMITED PARTNERSHIP

5503 Greenmont Ter, Vienna, WV 26105

Kalpana Shah
Soc signatory

MASSACHUSETTS RENTAL PROPERTIES, LLC

16 Swan Cir, Shrewsbury, MA 01545
10 Swan Cir, Shrewsbury, MA 01545

Publications

Us Patents

Lag-3-Binding Molecules And Methods Of Use Thereof

US Patent:

2019008, Mar 21, 2019

Filed:

Jun 7, 2016

Appl. No.:

15/580029

Inventors:

- Rockville MD, US
Kalpana Shah - Boyds MD, US
Douglas H. Smith - San Mateo CA, US
Leslie S. Johnson - Darnestown MD, US
Paul A. Moore - North Potomac MD, US
Ezio Bonvini - Potomac MD, US
Scott Koenig - Rockville MD, US

Assignee:

MacroGenics, Inc. - Rockville MD

International Classification:

C07K 16/28
A61P 31/04

Abstract:

The present invention is directed to the anti-LAG-3 antibodies, LAG-3 mAb 1, LAG-3 mAb 2, LAG-3 mAb 4, LAG-3 mAb 5, and LAG-3 mAb 6, and to humanized and chimeric versions of such antibodies. The invention additionally pertains to LAG-3-binding molecules that comprise LAG-3 binding fragments of such anti-LAG-3 antibodies, immunocongugates, and to bispecific molecules, including diabodies, BiTEs, bispecific antibodies, etc., that comprise (i) such LAG-3-binding fragments, and (ii) a domain capable of binding an epitope of a molecule involved in regulating an immune check point present on the surface of an immune cells. The present invention also pertains to methods of detecting LAG-3, as well as methods of using molecules that bind LAG-3 for stimulating immune responses.

Bispecific Molecules Having Immunoreactivity With Pd-1 And Ctla-4, And Methods Of Use Thereof

US Patent:

2019016, May 30, 2019

Filed:

Dec 12, 2016

Appl. No.:

16/060227

Inventors:

- Rockville MD, US
Gurunadh Reddy Chichili - Germantown MD, US
Kalpana Shah - Boyds MD, US
Paul A. Moore - North Potomac MD, US
Ezio Bonvini - Potomac MD, US
Scott Koenig - Rockville MD, US

Assignee:

MacroGenics, Inc. - Rockville MD

International Classification:

C07K 16/28
A61P 35/00
A61P 31/00
C07K 16/30
C07K 16/46

Abstract:

The present invention is directed to bispecific molecules (e.g., diabodies, bispecific antibodies, trivalent binding molecules, etc.) that possess at least one epitope-binding site that is immunospecific for an epitope of PD-1 and at least one epitope-binding site that is immunospecific for an epitope of CTLA-4 (i.e., a “PD-1×CTLA-4 bispecific molecule”). The PD-1×CTLA-4 bispecific molecules of the present invention are capable of simultaneously binding to PD-1 and to CTLA-4, particularly as such molecules are arrayed on the surfaces of human cells. The invention is directed to pharmaceutical compositions that contain such PD-1×CTLA-4 bispecific molecules, and to methods involving the use of such bispecific molecules in the treatment of cancer and other diseases and conditions. The present invention also pertains to methods of using such PD-1×CTLA-4 bispecific molecules to stimulate an immune response.

Bi-Specific Monovalent Fc Diabodies That Are Capable Of Binding Cd32B And Cd79B And Uses Thereof

US Patent:

2016019, Jul 7, 2016

Filed:

Aug 6, 2014

Appl. No.:

14/909820

Inventors:

- Rockville MD, US
Ling Huang - Bethesda MD, US
Kalpana Shah - Boyds MD, US
Ezio Bonvini - Potomac MD, US
Paul A. Moore - Bethesda MD, US
Wei Chen - Gaithersburg MD, US

Assignee:

MacroGenics, Inc. - Rockville MD

International Classification:

C07K 16/28
C07K 16/46

Abstract:

The present invention is directed to bi-specific monovalent diabodies that comprise an immunoglobulin Fc Domain (“bi-specific monovalent Fc diabodies”) and are composed of three polypeptide chains and which possess at least one binding site specific for an epitope of CD32B and one binding site specific for an epitope of CD79b (i.e., a “CD32B×CD79b bi-specific monovalent Fc diabody”). The bi-specific monovalent Fc diabodies of the present invention are capable of simultaneous binding to CD32B and CD79b. The invention is directed to such compositions, to pharmaceutical compositions that contain such bi-specific monovalent Fc diabodies and to methods for their use in the treatment of inflammatory diseases or conditions, and in particular, systemic lupus erythematosus (SLE) and graft vs. host disease.

Covalently Bonded Diabodies Having Immunoreactivity With Pd-1 And Lag-3, And Methods Of Use Thereof

US Patent:

2019016, Jun 6, 2019

Filed:

Nov 13, 2018

Appl. No.:

16/189071

Inventors:

- Rockville MD, US
Leslie S. Johnson - Darnestown MD, US
Kalpana Shah - Boyds MD, US
Paul A. Moore - North Potomac MD, US
Scott Koenig - Rockville MD, US

Assignee:

MacroGenics, Inc. - Rockville MD

International Classification:

C07K 16/28
C07K 16/46

Abstract:

The present invention is directed to bi-specific diabodies that comprise two or more polypeptide chains and which possess at least one Epitope-Binding Site that is immunospecific for an epitope of PD-1 and at least one Epitope-Binding Site that is immunospecific for an epitope of LAG-3 (i.e., a “PD-1×LAG-3 bi-specific diabody”). More preferably, the present invention is directed to bi-specific diabodies that comprise four polypeptide chains and which possess two Epitope-Binding Sites that are immunospecific for one (or two) epitope(s) of PD-1 and two Epitope-Binding Site that are immunospecific for one (or two) epitope(s) of LAG-3 (i.e., a “PD-1×LAG-3 bi-specific, tetra-valent diabody”). The present invention also is directed to such diabodies that additionally comprise an immunoglobulin Fc Domain (“bi-specific Fc diabodies and bi-specific, tetra-valent, Fc diabodies”). The diabodies of the present invention are capable of simultaneously binding to PD-1 and to LAG-3, particularly as such molecules are arrayed on the surfaces of human cells. The invention is directed to pharmaceutical compositions that contain such diabodies, and to methods involving the use of such diabodies in the treatment of cancer and other diseases and conditions.

Bi-Specific Monovalent Fc Diabodies That Are Capable Of Binding Cd32B And Cd79B And Uses Thereof

US Patent:

2019027, Sep 5, 2019

Filed:

May 15, 2019

Appl. No.:

16/412839

Inventors:

- Rockville MD, US
Ling Huang - Bethesda MD, US
Kalpana Shah - Boyds MD, US
Ezio Bonvini - Potomac MD, US
Paul A. Moore - North Potomac MD, US
Wei Chen - Gaithersburg MD, US

Assignee:

MacroGenics, Inc. - Rockville MD

International Classification:

C07K 16/28
C07K 16/46

Abstract:

Bi-Specific Monovalent Diabodies That Are Capable Of Binding To Gpa33 And Cd3, And Uses Thereof

US Patent:

2016022, Aug 4, 2016

Filed:

Aug 20, 2014

Appl. No.:

14/913654

Inventors:

- Rockville MD, US
Jonathan Li - Millbrae CA, US
Francine Zhifen Chen - San Francisco CA, US
Leslie S. Johnson - Darnestown MD, US
Kalpana Shah - Boyds MD, US
Ezio Bonvini - Potomac MD, US

Assignee:

MacroGenics, Inc. - Rockville MD

International Classification:

C07K 16/28
C07K 16/30

Abstract:

The present invention is directed to bi-specific monovalent diabodies that comprise two polypeptide chains and which possess at least one binding site specific for an epitope of CD3 and one binding site specific for an epitope of gpA33 (i.e., a “gpA33×CD3 bi-specific monovalent diabody”). The present invention also is directed to bi-specific monovalent diabodies that comprise an immunoglobulin Fc Domain (“bi-specific monovalent Fc diabodies”) and are composed of three polypeptide chains and which possess at least one binding site specific for an epitope of gpA33 and one binding site specific for an epitope of CD3 (i.e., a “gpA33×CD3 bi-specific monovalent Fc diabody”). The bi-specific monovalent diabodies and bi-specific monovalent Fc diabodies of the present invention are capable of simultaneous binding to gpA33 and CD3. The invention is directed to pharmaceutical compositions that contain such bi-specific monovalent diabodies or such bi-specific monovalent Fc diabodies. The invention is additionally directed to methods for the use of such diabodies in the treatment of cancer and other diseases and conditions.

Tri-Specific Binding Molecules That Specifically Bind To Multiple Cancer Antigens And Methods Of Use Thereof

US Patent:

2020019, Jun 25, 2020

Filed:

Feb 28, 2020

Appl. No.:

16/805105

Inventors:

- ROCKVILLE MD, US
Paul A. MOORE - Rockville MD, US
Jonathan C. LI - Rockville MD, US
Leslie S. JOHNSON - Rockville MD, US
Kalpana SHAH - Rockville MD, US

International Classification:

C07K 16/28
C07K 16/30

Abstract:

The present invention relates to Tri-Specific Binding Molecules, which are multi-chain polypeptide molecules that possess three Binding Domains and are thus capable of mediating coordinated binding to three epitopes. The Tri-Specific Binding Molecule is preferably characterized in possessing binding domains that permit it to immunospecifically bind to: (1) an epitope of a first Cancer Antigen, (2) an epitope of a second Cancer Antigen, and (3) an epitope of a molecule that is expressed on the surface of an immune system effector cell, and are thus capable of localizing an immune system effector cell to a cell that expresses a Cancer Antigen, so as to thereby facilitate the killing of such cancer cell.

Multi-Chain Polypeptide-Containing Tri-Specific Binding Molecules That Specifically Bind To Multiple Cancer Antigens

US Patent:

2020020, Jul 2, 2020

Filed:

Mar 13, 2020

Appl. No.:

16/818893

Inventors:

- Rockville MD, US
Ling HUANG - Rockville MD, US
Gurunadh Reddy CHICHILI - Rockville MD, US
Kalpana SHAH - Rockville MD, US
Chia-Ying Kao LAM - Rockville MD, US
Stephen James BURKE - Rockville MD, US
Liqin LIU - Rockville MD, US
Paul A. MOORE - Rockville MD, US
Ezio BONVINI - Rockville MD, US
Bhaswati BARAT - Rockville MD, US

International Classification:

C07K 16/28
C07K 16/30

Abstract:

The present invention relates to Tri-Specific Binding Molecules, which are multi-chain polypeptide molecules that possess three Binding Domains and are thus capable of mediating coordinated binding to three epitopes. The Binding Domains may be selected such that the Tri-Specific Binding Molecules are capable of binding to any three different epitopes. Such epitopes may be epitopes of the same antigen or epitopes of two or three different antigens. In a preferred embodiment, one of such epitopes will be capable of binding to CD3, the second of such epitopes will be capable of binding to CD8, and the third of such epitopes will be capable of binding to an epitope of a Disease-Associated Antigen. The invention also provides a novel ROR1-binding antibody, as well as derivatives thereof and uses for such compositions.

Videos & Images

Youtube

News Bulletin By Kalpana Shah From Bizz News Channel.mp4

Duration:

2m 35s

Category:

News & Politics

Description:

News Bulletin by KALPANA SHAH from BIZZ NEWS CHANNEL

Mar Gaini Daiya (The Great Hero Hiralal) (Bhojpuri)

Duration:

3m 28s

Category:

Trailers

Description:

Song from the Bhojpuri Film "The Great Hero Hiralal" Starring Pankaj Kesari, Monalisa, Nirmal Pandey, Manish Mahiwal, Jafar Khan, Priya Sharma, Kalpana Shah, Seema Singh, Rajesh Tomar & Others Director Sanoj Mishra Music Gunwant Sen Audio Venus

Smart Money Aspire - How To Invest In Art?

Duration:

4m 53s

Category:

Autos & Vehicles

Description:

In this episode of Smart Money Aspire we speak to Kalpana Shah, Owner, Tao Art Gallery, about how to invest in art and the young artists to watch!

Ham Hai Hero Hiralal (The Great Hero Hiralal) (Bhojpuri)

Duration:

3m 26s

Category:

Trailers

Description:

Nazar Se Girawal (The Great Hero Hiralal) (Bhojpuri)

Duration:

5m 9s

Category:

Trailers

Description:

Mahajan Darshan Clips

Duration:

Category:

Entertainment

Description:

Clips from Ideas Unlimited's Gujarati theatre production, Mahajan Darshan. Directed by Manoj Shah, Starring Kalpana Shah, Vimal Upadhyay, Nilesh Joshi, Satchit Puranik, Chirag Dave.

E Jinigiya Har Kehu (The Great Hero Hiralal) (Bhojpuri)

Duration:

5m 29s

Category:

Trailers

Description:

Hanif Khokhar's Video Golden Blouse In Keshod.

Duration:

1m 22s

Category:

News & Politics

Description:

ZEE NEWS / ZEE GUJARATI NEWS reporter HANIF KHOKHAR presant a spesial story. anchor KALPANA SHAH voice ASHUTOSH VYASH. A jeweler in the city of Junagadh Gujarat Keshod made a gold Blouse, whose value of 61 Lakes rupees, creating by ASHOK SAMTA, DEEPA SONI, AJ JEWELER - KESHOD (GUJARAT) INDIA.

FAQ: Learn more about Kalpana Shah

Where does Kalpana Shah live?

Syosset, NY is the place where Kalpana Shah currently lives.

How old is Kalpana Shah?

Kalpana Shah is 65 years old.

What is Kalpana Shah date of birth?

Kalpana Shah was born on 1959.

What is the main specialties of Kalpana Shah?

Kalpana is a Anesthesiology

Where has Kalpana Shah studied?

Kalpana studied at Jawaharlal Nehru Medical College, Bhagalpur

What is Kalpana Shah's email?

Kalpana Shah has such email addresses: ks***@rcn.com, bcsh***@aol.com, msha***@comcast.net, air234***@aol.com, di***@msn.com, dsha***@hotmail.com. Note that the accuracy of these emails may vary and they are subject to privacy laws and restrictions.

What is Kalpana Shah's telephone number?

Kalpana Shah's known telephone numbers are: 301-540-4386, 313-881-0773, 714-693-7445, 718-347-7075, 732-388-1217, 732-409-1310. However, these numbers are subject to change and privacy restrictions.

How is Kalpana Shah also known?

Kalpana Shah is also known as: Kalpana M Shah, Kalpana A Shah, Shantaben Shah, Kalpana J Oza. These names can be aliases, nicknames, or other names they have used.

Who is Kalpana Shah related to?

Known relatives of Kalpana Shah are: Blast Zone, Saumil Shah, Shantaben Shah, Jitendra Oza, Robbie Bahl, Deepinder Bhasin, Singh Daljinder. This information is based on available public records.

What are Kalpana Shah's alternative names?

Known alternative names for Kalpana Shah are: Blast Zone, Saumil Shah, Shantaben Shah, Jitendra Oza, Robbie Bahl, Deepinder Bhasin, Singh Daljinder. These can be aliases, maiden names, or nicknames.

Ages	53 to 78
Phones	301-540-4386	313-881-0773	714-693-7445
Addresses	11040 Schwab Dr, Cleveland, OH 44130	5250 Little Woods Ln, Dayton, OH 45429	4841 Westminster Ln, Broadview Heights, OH 44147
Business records	CSR / Needham bank	Senior Manager, Global Human Resources / Nanometrics	Senior Resolution Specialist / Educational Testing Service (Ets)

Kalpana Shah

What do we know about Kalpana Shah

Public information about Kalpana Shah

Resumes

Resumes

Qa Analyst

Kalpana Shah

Development Manager At Merck

Medical Technologist

Pharmacy Technician

Kalpana Shah

Phebotomy And Ekg

Packaging Supervisor

Phones & Addresses

Business Records

Publications

Us Patents

Lag-3-Binding Molecules And Methods Of Use Thereof

Bispecific Molecules Having Immunoreactivity With Pd-1 And Ctla-4, And Methods Of Use Thereof

Bi-Specific Monovalent Fc Diabodies That Are Capable Of Binding Cd32B And Cd79B And Uses Thereof

Covalently Bonded Diabodies Having Immunoreactivity With Pd-1 And Lag-3, And Methods Of Use Thereof

Bi-Specific Monovalent Fc Diabodies That Are Capable Of Binding Cd32B And Cd79B And Uses Thereof

Bi-Specific Monovalent Diabodies That Are Capable Of Binding To Gpa33 And Cd3, And Uses Thereof

Tri-Specific Binding Molecules That Specifically Bind To Multiple Cancer Antigens And Methods Of Use Thereof

Multi-Chain Polypeptide-Containing Tri-Specific Binding Molecules That Specifically Bind To Multiple Cancer Antigens

FAQ: Learn more about Kalpana Shah

Possible Relatives